Namibia Pharmaceuticals & Healthcare Q4 2020

Namibia Pharmaceuticals & Healthcare Q4 2020

Key View:

Having recorded very few cases at the start of the Covid-19 pandemic, Namibia is now dealing with a rapid increase inthe number of infections and deaths. This has prompted us to upwardly revise our healthcare spending forecast for 2020, as thecountry also continues to rely on foreign-funded training programmes and medicine donations to help its response to the situation.


Key View
Namibia Pharmaceuticals & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Namibia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook